Independent Research on Mutual Funds, Stocks & IPOs for Indian Investors

Supriya Lifescience Limited has informed the Exchange about Transcript | Supriya Lifescience Limited has informed the Exchange about Link of Recording | Supriya Lifescience Limited has informed the Exchange about Copy of Newspaper Publication | Supriya Lifescience Limited has informed the Exchange regarding a press release dated August 13, 2026, titled "Press Release for Unaudited Financial Results for quarter ended June 30, 2026". | Supriya Lifescience Limited has informed the Exchange regarding 'Unaudited Financial Results for Quarter ended June 30, 2026'. | Supriya Lifescience Limited has informed the Exchange about Investor Presentation | Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the Company at its Meeting held on Thursday, August 13, 2026, inter-alia considered and approved Unaudited Financial Results for the Quarter ended June 30, 2026. A copy of the same is enclosed along with the Limited Review Report of the Statutory Auditors thereon in terms of SEBI (LODR) Regulations, 2015. The Meeting of the Board of Directors of the Company commenced at 03:30 p.m. and concluded at 06.00 p.m.Kindly take the above information on your records.